TR201005419A2 - Valsartan içeren farmasötik bileşim. - Google Patents

Valsartan içeren farmasötik bileşim.

Info

Publication number
TR201005419A2
TR201005419A2 TR2010/05419A TR201005419A TR201005419A2 TR 201005419 A2 TR201005419 A2 TR 201005419A2 TR 2010/05419 A TR2010/05419 A TR 2010/05419A TR 201005419 A TR201005419 A TR 201005419A TR 201005419 A2 TR201005419 A2 TR 201005419A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
composition containing
containing valsartan
valsartan
pharmaceutically acceptable
Prior art date
Application number
TR2010/05419A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/05419A priority Critical patent/TR201005419A2/tr
Priority to PCT/TR2011/000168 priority patent/WO2012005709A2/en
Publication of TR201005419A2 publication Critical patent/TR201005419A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş; valsartan içeren granüller ile birlikte isteğe bağlı olarak farmasötik açıdan kabul edilebilir yardımcı maddelerden oluşmuş bir farmasötik bileşim ile ilgilidir.
TR2010/05419A 2010-07-05 2010-07-05 Valsartan içeren farmasötik bileşim. TR201005419A2 (tr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2010/05419A TR201005419A2 (tr) 2010-07-05 2010-07-05 Valsartan içeren farmasötik bileşim.
PCT/TR2011/000168 WO2012005709A2 (en) 2010-07-05 2011-07-04 Pharmaceutical composition comprising valsartan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/05419A TR201005419A2 (tr) 2010-07-05 2010-07-05 Valsartan içeren farmasötik bileşim.

Publications (1)

Publication Number Publication Date
TR201005419A2 true TR201005419A2 (tr) 2012-01-23

Family

ID=44741699

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/05419A TR201005419A2 (tr) 2010-07-05 2010-07-05 Valsartan içeren farmasötik bileşim.

Country Status (2)

Country Link
TR (1) TR201005419A2 (tr)
WO (1) WO2012005709A2 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3342400A1 (en) * 2016-12-31 2018-07-04 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. A pharmaceutical composition comprising valsartan and chlorthalidone

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0443983B1 (de) 1990-02-19 1996-02-28 Ciba-Geigy Ag Acylverbindungen
TR200703568A1 (tr) * 2007-05-24 2008-07-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Valsartan formülasyonları
GB0715628D0 (en) * 2007-08-10 2007-09-19 Generics Uk Ltd Solid valsartan composition
CN101744813A (zh) * 2010-01-21 2010-06-23 扬子江药业集团有限公司 复方氨氯地平缬沙坦固体制剂及其制备方法

Also Published As

Publication number Publication date
WO2012005709A3 (en) 2012-07-12
WO2012005709A2 (en) 2012-01-12

Similar Documents

Publication Publication Date Title
IL224976A (en) Converted history of 1h - indazole and a pharmaceutical preparation containing them
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
BR112013008259A2 (pt) composto, composição farmacêutica, e, uso de um composto
DK3246018T3 (da) Farmaceutisk sammensætning
BR112013015397A2 (pt) composto, composição farmacêutica, e, uso de um composto
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
GT201200303A (es) Formulaciones farmacéuticas
EE201300005A (et) Ravimkoostis
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
DK2542224T3 (da) Oral farmaceutisk sammensætning indeholdende dabigatranetexilat
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
HK1249519A1 (zh) Hsp90c端抑制劑及其醫藥組合物和用途
BR112012031967A2 (pt) composto, uso de um composto, combinação de um composto e composição farmacêutica
EP2560614A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR ADMINISTRATION
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
ZA201302012B (en) Low dose pharmaceutical composition
UA113977C2 (xx) Фармацевтична композиція з покращеною стабільністю
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
EP2544542A4 (en) PAIN COMPOUNDS, COMPOSITIONS AND THEIR USE
FR2958166B1 (fr) Compositions pharmaceutiques fortement dosees en biotine
TR201000689A1 (tr) Sefprozil içeren katı dozaj formlar.